PharmGKB summary: very important pharmacogene information for CYP3A5LAMBA, Jatinder; HEBERT, Joan M; SCHUETZ, Erin G et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 7, pp 555-558, issn 1744-6872, 4 p.Article

A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet NetworkASLIBEKYAN, Stella; KABAGAMBE, Edmond K; ORDOVAS, Jose M et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 3, pp 191-197, issn 1744-6872, 7 p.Article

Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipientsWOILLARD, Jean-Baptiste; KAMAR, Nassim; ROUSSEAU, Annick et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 10, pp 725-732, issn 1744-6872, 8 p.Article

Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1WEN LIU; POOLE, Elizabeth M; ULRICH, Cornelia M et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 7, pp 525-537, issn 1744-6872, 13 p.Article

Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysisBARBARA ANNE JENNINGS; CHUN SHING KWOK; WILLIS, Gavin et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 4, pp 290-304, issn 1744-6872, 15 p.Article

Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementationMENON, Saras; LEA, Rod A; ROY, Bishakha et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 10, pp 741-749, issn 1744-6872, 9 p.Article

Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcriptsRASOULI, Neda; KERN, Philip A; ELBEIN, Steven C et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 7, pp 484-497, issn 1744-6872, 14 p.Article

Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipientsBOUAMAR, Rachida; HESSELINK, Dennis A; VAN SCHAIK, Ron H. N et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 6, pp 399-407, issn 1744-6872, 9 p.Article

PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipientsLACHANCE, Kim; BARHDADI, Amina; DUBE, Marie-Pierre et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 5, pp 336-343, issn 1744-6872, 8 p.Article

The new CYP3A4 intron 6 C>T polymorphism (CYP3A4^*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patientsEVENS, Laure; BOUAMAR, Rachida; HESSELINK, Dennis A et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 5, pp 373-380, issn 1744-6872, 8 p.Article

ADH4 intronic variations are associated with alcohol dependence: results from an Italian case-control association studyTURCHI, Chiara; PIVA, Francesco; SOLITO, Giovanni et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 2, pp 79-94, issn 1744-6872, 16 p.Article

Doxorubicin pathways: pharmacodynamics and adverse effectsTHORN, Caroline F; OSHIRO, Connie; MARSH, Sharon et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 7, pp 440-446, issn 1744-6872, 7 p.Article

PharmGKB: very important pharmacogene ― HMGCRWONG MEDINA, Marisa; SANGKUHL, Katrin; KLEIN, Teri E et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 2, pp 98-101, issn 1744-6872, 4 p.Article

Angiotensin-converting enzyme tag single nucleotide polymorphisms in patients with intracerebral hemorrhageDARDIOTIS, Efthimios; JAGIELLA, Jeremiasz; HADJIGEORGIOU, Georgios M et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 3, pp 136-141, issn 1744-6872, 6 p.Article

Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian menOTT, Christian; SCHNEIDER, Markus P; DELLES, Christian et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 6, pp 347-349, issn 1744-6872, 3 p.Article

Association of GSTM1 null polymorphism with isosorbide-5-mononitrate cardiovascular response and involvement of CGRP in healthy Chinese male volunteersREN GUO; LEI CHEN; LING LI et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 3, pp 142-151, issn 1744-6872, 10 p.Article

Association of the UGT1A1-53(TA)_n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancerVARGENS, Daniela D; NEVES, Ronaldo R. S; BULZICO, Daniel A et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 6, pp 341-343, issn 1744-6872, 3 p.Article

Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesisBUSHEY, Ryan T; GANG CHEN; BLEVINS-PRIMEAU, Andrea S et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 2, pp 55-65, issn 1744-6872, 11 p.Article

Common polymorphisms in FMO1 are associated with nicotine dependenceHINRICHS, Anthony L; MURPHY, Sharon E; WANG, Jen C et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 7, pp 397-402, issn 1744-6872, 6 p.Article

Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genesTEICHERT, Martina; EIJGELSHEIM, Mark; UITTERLINDEN, Andre G et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 1, pp 26-34, issn 1744-6872, 9 p.Article

Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2)MEGARAJ, Vandana; TIANYONG ZHAO; PAUMI, Christian M et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 8, pp 506-515, issn 1744-6872, 10 p.Article

Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patientsSHAHIN, Mohamed Hossam A; KHALIFA, Sherief I; YAN GONG et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 3, pp 130-135, issn 1744-6872, 6 p.Article

Genetic epidemiology of induced CYP3A4 activityRAHMIOGLU, Nilufer; HEATON, James; AHMADI, Kourosh R et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 10, pp 642-651, issn 1744-6872, 10 p.Article

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatmentSWEN, Jesse J; GUCHELAAR, Henk-Jan; BAAK-PABLO, Renee F et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 8, pp 461-468, issn 1744-6872, 8 p.Article

Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotypeSELINSKI, Silvia; BLASZKEWICZ, Meinolf; BARSKI, Dimitri et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 10, pp 673-678, issn 1744-6872, 6 p.Article